Back to Authors

Kimmick, Gretchen G

Mayo Clinic

Wake Forest School of Medicine, Winston-Salem; Alliance Statistics and Data Center, Duke University; Duke University Medical Center, Durham; University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC; Alliance Statistics and Data

Citations 1

Comorbidity, Chemotherapy Toxicity, and Outcomes Among Older Women Receiving Adjuvant Chemotherapy for Breast Cancer on a Clinical Trial: CALGB 49907 and CALGB 361004 (Alliance)
Pitcher, Brandelyn N., Kornblith, Alice B., Hurria, Arti , Hudis, Clifford A. , Cohen, Harvey Jay, Muss, Hyman B. , Kimmick, Gretchen , Hudis, Clifford, Cohen, Harvey J, Kimmick, Gretchen G, Klepin, Heidi D. , Ballman, Karla V. , Winer, Eric P.

Journal of Oncology Practice | September 17, 2014 | Volume: 10 | Issue: 5 | Pages: e285-e292

10.1200/jop.2014.001388 Get It

Comorbidity was associated with shorter overall survival but not toxicity or relapse among older women with breast cancer with good functional status.